ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 162 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $200,000 | -95.3% | 3,900 | -95.9% | 0.02% | -96.0% |
Q3 2018 | $4,264,000 | -48.3% | 96,100 | -54.3% | 0.45% | -50.9% |
Q2 2018 | $8,248,000 | -13.9% | 210,468 | +58.9% | 0.92% | -12.2% |
Q1 2018 | $9,581,000 | +523.8% | 132,468 | +467.7% | 1.05% | +446.9% |
Q4 2017 | $1,536,000 | – | 23,333 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 2,818,835 | $33,967,000 | 11.67% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,713,176 | $20,644,000 | 0.58% |
Bellevue Group AG | 4,519,164 | $54,455,000 | 0.55% |
Rhenman & Partners Asset Management AB | 622,267 | $7,498,000 | 0.53% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 47,534 | $573,000 | 0.21% |
WASATCH ADVISORS LP | 3,274,360 | $39,456,000 | 0.16% |
EMC Capital Management | 27,566 | $246,000 | 0.14% |
PDT Partners, LLC | 120,828 | $1,456,000 | 0.10% |
Virtus ETF Advisers LLC | 17,773 | $214,000 | 0.09% |
Pinz Capital Management, LP | 15,300 | $184,000 | 0.08% |